CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 120 enrolled
Drug / intervention
nicotinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01476202
NCT01476202Phase 2Completed
CompareCT.gov

A Pilot Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Strip, Nicorette ® Nicotine Lozenge and Gum

GlaxoSmithKline·interventional·Posted Nov 22, 2011·Updated Sep 30, 2013

In Brief

A Phase 2 clinical trial evaluating nicotine for Smoking Cessation. Completed, enrolled 120 participants across 1 site.

Detailed Summary

This study is designed to assess the ability of the mint nicotine mouth strip to relieve provoked cigarette craving in light smokers compared to nicotine lozenge and nicotine gum.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 22, 2011
Enrollment StartNov 1, 2011
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.6 years ago

Interventions

nicotinedrug

nicotine in the form of a mouth strip, lozenge and gum